Luo YG, Wu M, Chen HG. Retrospective analysis of pathological types and imaging features in pancreatic cancer: A comprehensive study. World J Gastrointest Oncol 2025; 17(1): 99153 [DOI: 10.4251/wjgo.v17.i1.99153]
Corresponding Author of This Article
Yang-Gang Luo, Associate Chief Physician, Department of Imaging, Xuanhan County People’s Hospital, No. 579 Jiefang Middle Road, Dazhou 636150, Sichuan Province, China. lygxuanhan@163.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Oncol. Jan 15, 2025; 17(1): 99153 Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.99153
Retrospective analysis of pathological types and imaging features in pancreatic cancer: A comprehensive study
Yang-Gang Luo, Mei Wu, Hong-Guang Chen
Yang-Gang Luo, Mei Wu, Hong-Guang Chen, Pathology Department, Xuanhan County People’s Hospital, Dazhou 636150, Sichuan Province, China
Author contributions: Luo YG and Wu M proposed the concept of this study, participated in the data collection, participated in this study, validated it, and jointly reviewed and edited the manuscript; Luo YG drafted the initial draft and guided the research, methodology, and visualization of the manuscript; Chen HG contributed to the formal analysis of this study. All authors critically reviewed and provided final approval of the manuscript; and all authors were responsible for the decision to submit the manuscript for publication.
Institutional review board statement: This study has been approved and reviewed by the Ethics Committee of Xuanhan County People’s Hospital, No. 2021-LL-092.
Informed consent statement: Due to the retrospective nature of the study, informed consent was waived.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: No available data.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yang-Gang Luo, Associate Chief Physician, Department of Imaging, Xuanhan County People’s Hospital, No. 579 Jiefang Middle Road, Dazhou 636150, Sichuan Province, China. lygxuanhan@163.com
Received: August 26, 2024 Revised: September 23, 2024 Accepted: October 15, 2024 Published online: January 15, 2025 Processing time: 108 Days and 1.4 Hours
Core Tip
Core Tip: Understanding the correlation between the pathological types of pancreatic cancer and their corresponding imaging features is crucial for early detection and treatment planning. Different types of pancreatic cancers exhibit distinct imaging characteristics, such as hypodense masses with poorly defined borders for pancreatic ductal adenocarcinoma, cystic lesions with mural nodules for intraductal papillary mucinous neoplasm, and hypervascular lesions for neuroendocrine tumors. Utilization of a combination of computed tomography, magnetic resonance imaging, and endoscopic ultrasound can aid in an accurate diagnosis. This knowledge can significantly improve diagnostic accuracy, inform personalized treatment strategies, and potentially enhance outcomes in patients with pancreatic cancer.
